DRD2 and Parkinson disease: One of the pathological hallmarks of PD is dopaminergic neuron loss, and postmortem studies have confirmed that human brainstem regions, such as the substantia nigra, red nucleus, medial lemniscus, and pontine nucleus, highly express D2 dopamine receptor mRNAs [33].